| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
11,814 |
10,838 |
$1.04M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
7,713 |
6,713 |
$727K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,263 |
2,820 |
$349K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,819 |
1,607 |
$220K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,699 |
867 |
$183K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,943 |
2,478 |
$176K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,088 |
1,941 |
$166K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
959 |
863 |
$154K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
664 |
599 |
$111K |
| 80053 |
Comprehensive metabolic panel |
9,376 |
7,665 |
$103K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,711 |
1,378 |
$103K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,264 |
1,673 |
$84K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
427 |
383 |
$71K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,227 |
1,758 |
$63K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
506 |
482 |
$49K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,019 |
890 |
$46K |
| 71045 |
Radiologic examination, chest; single view |
3,677 |
3,198 |
$45K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
1,005 |
632 |
$42K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,696 |
1,310 |
$29K |
| 84484 |
|
2,655 |
1,841 |
$28K |
| 81001 |
|
2,881 |
2,557 |
$23K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
504 |
458 |
$21K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
10,383 |
8,281 |
$17K |
| 81003 |
|
2,050 |
1,824 |
$17K |
| 71046 |
Radiologic examination, chest; 2 views |
509 |
464 |
$16K |
| 36415 |
Collection of venous blood by venipuncture |
1,996 |
1,444 |
$16K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
2,204 |
2,032 |
$14K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
346 |
298 |
$14K |
| G0378 |
Hospital observation service, per hour |
272 |
141 |
$12K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,915 |
3,226 |
$12K |
| 82947 |
|
1,140 |
494 |
$12K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,135 |
1,030 |
$11K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
353 |
187 |
$11K |
| 81025 |
|
1,338 |
1,256 |
$9K |
| 80061 |
Lipid panel |
872 |
804 |
$9K |
| 73630 |
|
146 |
133 |
$9K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
477 |
468 |
$9K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
86 |
76 |
$8K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
123 |
110 |
$8K |
| 96376 |
|
166 |
102 |
$7K |
| 01999 |
|
274 |
263 |
$6K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
3,457 |
2,517 |
$5K |
| 83735 |
|
1,723 |
1,302 |
$5K |
| 85610 |
|
2,635 |
2,161 |
$4K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
12 |
12 |
$4K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
199 |
181 |
$4K |
| 85730 |
|
2,026 |
1,727 |
$3K |
| 73130 |
|
26 |
25 |
$3K |
| 83605 |
|
1,008 |
771 |
$3K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
66 |
58 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
435 |
337 |
$3K |
| 87070 |
|
87 |
77 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
591 |
534 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,939 |
1,503 |
$2K |
| 84702 |
|
154 |
112 |
$2K |
| 83880 |
|
292 |
260 |
$2K |
| 73110 |
|
27 |
26 |
$1K |
| 87040 |
|
1,076 |
556 |
$1K |
| J2060 |
Injection, lorazepam, 2 mg |
79 |
66 |
$1K |
| 83690 |
|
1,943 |
1,679 |
$1K |
| 82077 |
|
16 |
13 |
$884.59 |
| 73610 |
|
32 |
29 |
$737.79 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
54 |
53 |
$669.54 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
26 |
25 |
$661.82 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
420 |
257 |
$632.33 |
| 84703 |
|
740 |
674 |
$543.86 |
| 73562 |
|
13 |
12 |
$522.58 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
40 |
39 |
$460.65 |
| 0225U |
|
14 |
14 |
$436.64 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
19 |
15 |
$377.49 |
| 74018 |
|
12 |
12 |
$309.06 |
| 85379 |
|
180 |
168 |
$281.87 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,471 |
1,261 |
$258.78 |
| 80050 |
General health panel |
13 |
13 |
$255.81 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,252 |
878 |
$168.54 |
| 87077 |
|
201 |
177 |
$81.58 |
| 82565 |
|
62 |
51 |
$73.20 |
| J7050 |
Infusion, normal saline solution, 250 cc |
302 |
197 |
$71.16 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
226 |
209 |
$50.99 |
| 85027 |
|
276 |
214 |
$46.13 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
77 |
68 |
$37.88 |
| 86140 |
|
33 |
28 |
$25.12 |
| 84439 |
|
76 |
64 |
$20.45 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
251 |
218 |
$14.61 |
| 85007 |
|
29 |
24 |
$3.51 |
| 84520 |
|
18 |
13 |
$1.68 |
| J2704 |
Injection, propofol, 10 mg |
35 |
26 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
84 |
81 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
32 |
26 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
13 |
12 |
$0.00 |
| 84132 |
|
16 |
12 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
14 |
12 |
$0.00 |
| 86901 |
|
58 |
55 |
$0.00 |
| 86850 |
|
13 |
12 |
$0.00 |
| 85652 |
|
16 |
13 |
$0.00 |
| 87186 |
|
260 |
227 |
$0.00 |
| 80305 |
|
25 |
25 |
$0.00 |
| 86900 |
|
59 |
55 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
36 |
30 |
$0.00 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
14 |
13 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
18 |
12 |
$0.00 |